Assignee
SHORLA PHARMA LTD
IE·2 granted patents·3 pending applications·0 citations·filing 2018–2024
Technology mixA61K5
Top patents by PatentIndex Score
5 records- 0169US2024216373A1Liquid dosage forms of imatinibSHORLA PHARMA LTD·Filed 2024·Application pending·0 cites
- 0262US11957681B2Liquid dosage forms of ImatinibSHORLA PHARMA LTD·Filed 2018·Granted Apr 16, 2024·0 cites·1 claims
- 0361US11975013B2Stable formulations comprising thiotepaSHORLA PHARMA LTD·Filed 2022·Granted May 7, 2024·0 cites·13 claims
- 0456US2023041156A1Stable formulations comprising thiotepaSHORLA PHARMA LTD·Filed 2022·Application pending·0 cites
- 0554US2025017918A1Oral suspensions comprising temozolomide or lenalidomideSHORLA PHARMA LTD·Filed 2024·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →